• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠:多囊肾病的临床前模型

The Rat: A Preclinical Model of Polycystic Kidney Disease.

作者信息

Kofotolios Ioannis, Bonios Michael J, Adamopoulos Markos, Mourouzis Iordanis, Filippatos Gerasimos, Boletis John N, Marinaki Smaragdi, Mavroidis Manolis

机构信息

Clinic of Nephrology and Renal Tranplantation, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Center of Basic Research, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.

出版信息

Biomedicines. 2024 Feb 3;12(2):362. doi: 10.3390/biomedicines12020362.

DOI:10.3390/biomedicines12020362
PMID:38397964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10887417/
Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) stands as the most prevalent hereditary renal disorder in humans, ultimately culminating in end-stage kidney disease. Animal models carrying mutations associated with polycystic kidney disease have played an important role in the advancement of ADPKD research. The rat model, carrying an R823W mutation in the gene, is characterized by cyst formation and kidney enlargement. The mutated protein, named Samcystin, is localized in cilia of tubular epithelial cells and seems to be involved in cystogenesis. The homozygous mutation leads to end-stage renal disease and death, making it a critical factor in kidney development and function. This review explores the utility of the rat model, highlighting its phenotypic similarity to human ADPKD. Specifically, we discuss its role in preclinical trials and its importance for investigating the pathogenesis of the disease and developing new therapeutic approaches.

摘要

常染色体显性多囊肾病(ADPKD)是人类最常见的遗传性肾脏疾病,最终会发展为终末期肾病。携带与多囊肾病相关突变的动物模型在ADPKD研究进展中发挥了重要作用。携带该基因突变中R823W突变的大鼠模型,其特征为囊肿形成和肾脏肿大。这种突变蛋白名为Samcystin,定位于肾小管上皮细胞的纤毛中,似乎参与了囊肿形成过程。纯合突变会导致终末期肾病和死亡,使其成为肾脏发育和功能的关键因素。本综述探讨了该大鼠模型的实用性,强调了其与人类ADPKD的表型相似性。具体而言,我们讨论了其在临床前试验中的作用,以及对于研究该疾病发病机制和开发新治疗方法的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/382738f99f1b/biomedicines-12-00362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/bac107a3ea64/biomedicines-12-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/d25c1b316c1f/biomedicines-12-00362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/382738f99f1b/biomedicines-12-00362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/bac107a3ea64/biomedicines-12-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/d25c1b316c1f/biomedicines-12-00362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a313/10887417/382738f99f1b/biomedicines-12-00362-g003.jpg

相似文献

1
The Rat: A Preclinical Model of Polycystic Kidney Disease.大鼠:多囊肾病的临床前模型
Biomedicines. 2024 Feb 3;12(2):362. doi: 10.3390/biomedicines12020362.
2
A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.一种用于常染色体显性多囊肾病大鼠模型肾细胞囊肿形成的新型体外生物测定法。
In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):571-9. doi: 10.1007/s11626-999-0095-4.
3
Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin.汉逊酵母相关性多囊肾病大鼠中 SamCystin 的表达升高和定位异常。
Am J Physiol Renal Physiol. 2010 Nov;299(5):F1078-86. doi: 10.1152/ajprenal.00504.2009. Epub 2010 Aug 18.
4
Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats.Anks6(p.R823W) 的转基因过表达导致大鼠多囊肾病。
Am J Pathol. 2010 Dec;177(6):3000-9. doi: 10.2353/ajpath.2010.100569.
5
Progression of renal failure in the Han: SPRD polycystic kidney rat.Han系SPRD多囊肾大鼠肾衰竭的进展
Nephrol Dial Transplant. 1994;9(12):1734-9.
6
Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat.首个控制Han:SPRD cy/+大鼠常染色体显性多囊肾病的基因座PKDr1的定位。
Hum Mol Genet. 1997 Apr;6(4):609-13. doi: 10.1093/hmg/6.4.609.
7
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).用西罗莫司抑制哺乳动物雷帕霉素靶蛋白(mTOR)可减缓常染色体显性遗传性多囊肾病(ADPKD)的Han:SPRD大鼠的疾病进展。
Nephrol Dial Transplant. 2006 Mar;21(3):598-604. doi: 10.1093/ndt/gfi181. Epub 2005 Oct 12.
8
The polycystic kidney disease-related proteins Bicc1 and SamCystin interact.多囊肾病相关蛋白Bicc1和SamCystin相互作用。
Biochem Biophys Res Commun. 2009 May 22;383(1):16-21. doi: 10.1016/j.bbrc.2009.03.113. Epub 2009 Mar 24.
9
The SAM domain of ANKS6 has different interacting partners and mutations can induce different cystic phenotypes.ANKS6 的 SAM 结构域具有不同的相互作用伙伴,突变可导致不同的囊泡表型。
Kidney Int. 2015 Aug;88(2):299-310. doi: 10.1038/ki.2015.122. Epub 2015 Jun 3.
10
Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.塞来昔布通过 VEGFRaf/MAPK/ERK 信号通路抑制人常染色体显性遗传性多囊肾病囊肿衬里上皮细胞的生长。
Mol Biol Rep. 2012 Jul;39(7):7743-53. doi: 10.1007/s11033-012-1611-2. Epub 2012 Mar 14.

引用本文的文献

1
Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease.多囊肾病发病机制的机制性见解
Cells. 2025 Aug 5;14(15):1203. doi: 10.3390/cells14151203.
2
Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids.常染色体显性多囊肾病建模的进展与挑战:聚焦肾类器官
Biomedicines. 2025 Feb 19;13(2):523. doi: 10.3390/biomedicines13020523.
3
Therapeutic Potential of Ketogenic Interventions for Autosomal-Dominant Polycystic Kidney Disease: A Systematic Review.生酮干预对常染色体显性多囊肾病的治疗潜力:一项系统评价

本文引用的文献

1
Cardiovascular Manifestations and Management in ADPKD.常染色体显性多囊肾病的心血管表现与管理
Kidney Int Rep. 2023 Aug 4;8(10):1924-1940. doi: 10.1016/j.ekir.2023.07.017. eCollection 2023 Oct.
2
Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease-A Retrospective Single-Arm Case Series Study.达格列净治疗常染色体显性多囊肾病的短期疗效——一项回顾性单臂病例系列研究
J Clin Med. 2023 Oct 3;12(19):6341. doi: 10.3390/jcm12196341.
3
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease.
Nutrients. 2024 Dec 31;17(1):145. doi: 10.3390/nu17010145.
某些丝氨酸/苏氨酸激酶 NEK8 激酶结构域中的杂合变体可导致常染色体显性多囊肾病。
Kidney Int. 2023 Nov;104(5):995-1007. doi: 10.1016/j.kint.2023.07.021. Epub 2023 Aug 19.
4
Intracranial Aneurysms in ADPKD: How Far Have We Come?常染色体显性多囊肾病中的颅内动脉瘤:我们已经取得了多大进展?
Clin J Am Soc Nephrol. 2019 Aug 1;14(8):1119-1121. doi: 10.2215/CJN.07570719. Epub 2019 Jul 30.
5
Sodium-glucose cotransporter inhibition in polycystic kidney disease: fact or fiction.多囊肾病中钠-葡萄糖协同转运蛋白抑制作用:事实还是虚构
Clin Kidney J. 2022 Jan 31;15(7):1275-1283. doi: 10.1093/ckj/sfac029. eCollection 2022 Jul.
6
Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion.通过巨噬细胞耗竭减轻 ANKS6 缺陷肝脏的门脉纤维化和胆汁淤积性肝病。
FASEB J. 2022 Feb;36(2):e22157. doi: 10.1096/fj.202101387R.
7
Nephronophthisis-Pathobiology and Molecular Pathogenesis of a Rare Kidney Genetic Disease.肾单位肾痨病:一种罕见遗传性肾脏疾病的病理生物学与分子发病机制。
Genes (Basel). 2021 Nov 5;12(11):1762. doi: 10.3390/genes12111762.
8
Biallelic ANKS6 mutations cause late-onset ciliopathy with chronic kidney disease through YAP dysregulation.双等位基因 ANKS6 突变通过 YAP 失调导致迟发性纤毛病伴慢性肾脏病。
Hum Mol Genet. 2022 May 4;31(9):1357-1369. doi: 10.1093/hmg/ddab322.
9
Nephronophthisis gene products display RNA-binding properties and are recruited to stress granules.肾单位发生不全基因产物显示 RNA 结合特性,并被招募到应激颗粒中。
Sci Rep. 2020 Sep 29;10(1):15954. doi: 10.1038/s41598-020-72905-8.
10
Mineral bone disease in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的矿物质骨病。
Kidney Int. 2021 Apr;99(4):977-985. doi: 10.1016/j.kint.2020.07.041. Epub 2020 Sep 11.